podophyllotoxin has been researched along with Carcinoma 256, Walker in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norpoth, K; Rauen, HM | 1 |
| Stähelin, H | 1 |
| Osswald, H; Schmähl, D | 1 |
3 other study(ies) available for podophyllotoxin and Carcinoma 256, Walker
| Article | Year |
|---|---|
[Tumor-specific effects of substances of the podophyllotoxin and Verrucaria series on the chorioallantoic membrane tumor system].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chick Embryo; Culture Techniques; Extraembryonic Membranes; Neoplasms, Experimental; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Sarcoma, Experimental; Sarcoma, Yoshida | 1966 |
4'-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action.
Topics: Animals; Carcinoma 256, Walker; Culture Techniques; Female; Fibroblasts; Leukemia L1210; Male; Mast-Cell Sarcoma; Mice; Mitosis; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Rats | 1970 |
[Studies with Proresid (SP-I) in various innoculation tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Carcinosarcoma; Cyclophosphamide; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Rats; Sarcoma, Experimental; Sarcoma, Yoshida | 1966 |